Related Experiment Videos
Commercialisation of CAR T-cell therapies: business model spectrum
Nafees N Malik1, Matthew B Durdy2
1Asklepian Consulting, International House, 24 Holborn Viaduct, London EC1A 2BN, United Kingdom.
Drug Discovery Today
|November 21, 2016
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Toward a unified theory of aging and regeneration.
Regenerative medicine·2019
Key issues in the pharmaceutical industry: consequences on R&D.
Expert opinion on drug discovery·2013
Integration of diagnostic and communication technologies.
Journal of telemedicine and telecare·2009
Controlling the cost of innovative cancer therapeutics.
Nature reviews. Clinical oncology·2009
Revisiting the potential of elongation factors as drug targets for pathogenic mycobacteria.
Drug discovery today·2026
Strength of weakness in molecular interactions: toward transient medicines in drug discovery.
Drug discovery today·2026
Chemoproteomics in covalent cancer drug discovery.
Drug discovery today·2026
Patient-based evidence in mechanism-based drug repurposing: Challenges and recommendations.
Drug discovery today·2026
[Sacituzumab govitecan in a patient with early bone recurrence of triple-negative breast cancer refractory to first-line chemotherapy.]
Recenti progressi in medicina·2026
Quercetin Attenuates Cisplatin-Induced Nephrotoxicity While Enhancing Antitumor Efficacy in Gastric Cancer via Cell Type-Specific Modulation of the ERK1/2 Pathway.
Journal of biochemical and molecular toxicology·2026
Gedatolisib for the treatment of hormone receptor-positive/HER2-negative advanced breast cancer: a European perspective.
Future oncology (London, England)·2026
Stereotactic Ablative Body Radiotherapy Versus Microwave Ablation for the Treatment of Early-Stage Hepatocellular Carcinoma.
Journal of medical imaging and radiation oncology·2026